Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise.
The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise
The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.
To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
The USD 6+ billion (by 2030) financial opportunity -ociated with nuclear medicine and radiopharmaceuticals manufacturing, has been -yzed across the following segments:
Target Disease Indication
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
Head and Neck Cancer
Lung Cancer
Lupus Nephritis
Melanoma
Multiple Myeloma
Primary Sjögren's Syndrome
Others
Target Immune Checkpoint
B7-H3
CD38
CD40
CD47
Others
Mechanism of Action
Inhibitory
Stimulatory
Therapeutic Modality
Monoclonal Antibody
Small Molecule
Type of Therapy
Monotherapy
Combination Therapy
Route of Administration
Intravenous
Subcutaneous
Others
Key Geographical Regions
North America
Europe
Asia-Pacific and the Rest of the World
The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:
Advanced Accelerator Applications
Belgian Nuclear Research Center (SCK•CEN)
Cardinal Health
China Isotope & Radiation Corporation
Curium Pharma
-mBio
Eckert & Ziegler
Eczacibasi-Monrol
GE Healthcare
Jubilant DraxImage
Lantheus Medical Imaging
Nihon Medi-Physics
Nordion
PETNET Solutions
SinoTau Pharmaceuticals
SOFIE
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Compe-iveness -ysis
10. Partner-ps and Collaborations
11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
12. Market Forecast and Opportunity -ysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@roots-ysis.com